Skip to main content
Caplight Logo









Excelsior Sciences

Excelsior Sciences

Private
New York City, New YorkHealthcare & Life Scienceshttps://excelsiorsci.com/

Last Round

Series A

Dec 3, 2025

Est. Valuation

$96M

Total Funding Raised

$70M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Excelsior Sciences is a biotechnology company that develops an automated chemistry platform and a machine-native chemical language to accelerate the discovery and manufacturing of small molecules.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Data Integration, Workflow Automation

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

drug discoverycomputational biologylaboratory automationAI-native drug discoveryclosed-loop discoverypredictive modelinglead optimizationbiotech softwareSaaSin silico drug discoveryAI-guided synthesisR&D automationusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Excelsior Sciences Comparables

Compare Excelsior Sciences with similar companies based on industry and business-model similarity.

Excelsior Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DeepCure
87%
Synfini
86%
Iktos
80%

Excelsior Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 3, 2025

Key People

Founding team and executive leadership

Michael Foley

Chief Executive Officer and Co-Founder

Founding Team

Marc Feiglin

Chief Technology Officer

Executive Team

Jana Jensen

Chief Operating Officer

Executive Team

Excelsior Sciences Investors

Notable investors and investment history

Excelsior Sciences investors
InvestorRounds
MITSeries A
Deerfield ManagementSeries A
Cornucopian CapitalSeries A
Khosla VenturesSeries A
Empire State DevelopmentSeries A
Sofinnova PartnersSeries A
Illinois VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 64% MoM, reaching 3.2K.

  • Jul 25, 2026

    Monthly visitors increased 54% MoM, from 1.3K to 2K.

Excelsior Sciences Filings

Explore SEC and related filing metadata, where available.

Excelsior Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Excelsior Sciences's valuation, stock price, and market status.

Is Excelsior Sciences a public or private company?

Excelsior Sciences is a private company.

What is the current stock price of Excelsior Sciences?

Excelsior Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is Excelsior Sciences worth (valuation)?

Valuation information for Excelsior Sciences is not publicly available.

Can I buy Excelsior Sciences stock?

Excelsior Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Excelsior Sciences's last funding round?

Excelsior Sciences's most recent funding round was Series A on December 4, 2025.

Who are the main investors in Excelsior Sciences?

Key investors in Excelsior Sciences include Deerfield Management, Khosla Ventures, Sofinnova Partners.

Will Excelsior Sciences IPO soon?

No public IPO plans have been announced for Excelsior Sciences.

How can I track Excelsior Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Excelsior Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range21
Year Founded2024
Last FundingDec 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?